SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 17.37% in the revenue at Rs. 6194.50 millions was reported in the March 2026 quarter as compared to Rs. 5277.80 millions during year-ago period.Handsome Net Profit growth of 68.18% reported above the corresponding previous quarter figure of Rs. 531.80 millions to Rs. 316.20 millions.Operating profit for the quarter ended March 2026 rose to 943.10 millions as compared to 674.60 millions of corresponding quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 6194.50 5277.80 17.37 23190.60 20792.10 11.54 23190.60 20792.10 11.54
Other Income 17.40 45.20 -61.50 212.80 224.00 -5.00 212.80 224.00 -5.00
PBIDT 943.10 674.60 39.80 2903.70 2245.70 29.30 2903.70 2245.70 29.30
Interest 32.10 40.30 -20.35 145.50 147.60 -1.42 145.50 147.60 -1.42
PBDT 911.00 634.30 43.62 2646.10 2098.10 26.12 2646.10 2098.10 26.12
Depreciation 202.70 185.30 9.39 801.70 719.20 11.47 801.70 719.20 11.47
PBT 708.30 449.00 57.75 1844.40 1378.90 33.76 1844.40 1378.90 33.76
TAX 176.50 132.80 32.91 467.20 368.90 26.65 467.20 368.90 26.65
Deferred Tax 25.30 62.20 -59.32 61.70 121.50 -49.22 61.70 121.50 -49.22
PAT 531.80 316.20 68.18 1377.20 1010.00 36.36 1377.20 1010.00 36.36
Equity 587.10 587.10 0.00 587.10 587.10 0.00 587.10 587.10 0.00
PBIDTM(%) 15.22 12.78 19.11 12.52 10.80 15.93 12.52 10.80 15.93

IOL Chem & Pharma Share Price

131.20 3.00 (2.34%)
19-Jun-2026 10:38 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1832.00
Dr. Reddys Lab 1262.30
Cipla 1356.30
Zydus Lifesciences 1075.40
Lupin 2332.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: